Accelerating Drug Discovery and Genetic Therapies through AI
Yutaniai is a leading biotechnology research platform, leveraging artificial intelligence to transform the landscape of drug discovery and genetic therapies. With a target valuation of $40 billion, we are committed to innovation and excellence in the biotechnology field.